EASi-HF™ Reduced Clinical Trial
EASi-HF Reduced - a phase 3 double-blind, randomized, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) <40%.
EASi-HF™ Reduced Clinical Trial
EASi-HF Reduced - a phase 3 double-blind, randomized, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) <40%.
Primary Hero
The Hero is your first opportunity to ‘wow’ a website visitor. To pique their interest, and to showcase your brand’s identity—by using highly visual and engaging content. It’s likely to be the first component visitors see, so you’ll want it to capture their attention.
There are more examples and designs that can be viewed on the Index page or clicking the link below.
Section Headline
Participating sites with their contact details are mentioned in the table below.
Alabama
Site | Contact # | |
| Pinnacle Research Group, LLC, Anniston, Alabama | 833-602-2368 | |
| Eastern Shore Research Group, Fairhope, Alabama | 833-602-2368 | |
| Lakeview Clinical Research, Guntersville, Alabama | 833-602-2368 |
Participating sites with their contact details are mentioned in the table below.
Arizona
Site | Contact # | |
| Elite Clinical Studies, Phoenix, Arizona | 833-602-2368 | |
| Clinical Research Institute of Arizona, LLC, Sun City West, Arizona | 833-602-2368 | |
| Fiel Family & Sports Medicine, Tempe, Arizona | 833-602-2368 | |
| Yuma Clinical Trials, Yuma, Arizona | 833-602-2368 |
Rich text
Boehringer Ingelheim is championing every mind for generations with innovative and holistic solutions in mental health
Boehringer Ingelheim is proud to be investigating the potential of prescription digital therapeutics in addressing gaps in care for those with serious mental health conditions.
With PDTs, Boehringer is bringing innovative treatment modalities to people living with serious mental health conditions so that they can create more meaningful connections to their lives, loved ones, and society.
På ettsamlatgrepp.se får patienter och anhöriga en pedagogisk och
stöttande genomgång av hur hjärt-kärlsjukdom, kronisk njursjukdom
och typ 2-diabetes hänger ihop och vad man kan göra för att må
bättre.
På hemsidan nns bland annat:
- Fördjupning i samsjukligheten mellan hjärtkärlsjukdom, kronisk
njursjukdom och typ 2-diabetes (HND) - Livsstilsråd
- Tips på frågor att ställa till vården
- Symtom och risker att vara uppmärksam på
Poddavsnitt med patientberättelser
Digitalt arbetsstöd för dig som möter patienter med hjärtkärlsjukdom, njursjukdom och typ 2-diabetes
Ta del av ett praktiskt, digitalt arbetsstöd som ger dig en snabb överblick och ett konkret beslutsunderlag
Article card with image on top
Article card with image on top
Article card with image on top
Section Headline
Simple card
Simple card
Simple card
Section Headline
Dabigatran etexilate
Dabigatran etexilate
Dabigatran etexilate
Accordion Test
Expand alltest content
test content 2
Info Footer
Για τις εγκεκριμένες ενδείξεις, τις ανεπιθύμητες ενέργειες, τις προειδοποιήσεις, τις αντεδείξεις, την δοσολογία, και οποιαδήποτε άλλη πληροφορία παρακαλούμε ανατρέξτε στην Περίληψη των Χαρακτηριστικών του Προϊόντος (ΠΧΠ)